Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.

Negreiros S, Farias S, Viana GM, Okoth SA, Chenet SM, de Souza TM, Marchesini P, Udhayakumar V, Povoa MM, Santelli AC, de Oliveira AM.

Am J Trop Med Hyg. 2016 Nov 2;95(5):1061-1068. Epub 2016 Aug 22.

2.

Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.

Yuan L, Wang Y, Parker DM, Gupta B, Yang Z, Liu H, Fan Q, Cao Y, Xiao Y, Lee MC, Zhou G, Yan G, Baird JK, Cui L.

Antimicrob Agents Chemother. 2015 Feb;59(2):1230-5. doi: 10.1128/AAC.04270-14. Epub 2014 Dec 15.

3.

In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.

Ganguly S, Saha P, Guha SK, Das S, Bera DK, Biswas A, Kundu PK, Saha B, Ray K, Maji AK.

Antimicrob Agents Chemother. 2013 Mar;57(3):1246-51. doi: 10.1128/AAC.02050-12. Epub 2012 Dec 21.

4.

Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.

Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, Setiabudy R, Nurleila S, Ekawati LL, Elyazar I, Farrar J, Sudoyo H, Baird JK.

Antimicrob Agents Chemother. 2013 Mar;57(3):1128-35. doi: 10.1128/AAC.01879-12. Epub 2012 Dec 17.

5.

Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P.

Antimicrob Agents Chemother. 2013 Feb;57(2):818-26. doi: 10.1128/AAC.00686-12. Epub 2012 Dec 3.

6.

In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China.

Lu F, Gao Q, Chotivanich K, Xia H, Cao J, Udomsangpetch R, Cui L, Sattabongkot J.

Am J Trop Med Hyg. 2011 Aug;85(2):197-201. doi: 10.4269/ajtmh.2011.10-0070.

7.

Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.

Muhamad P, Ruengweerayut R, Chacharoenkul W, Rungsihirunrat K, Na-Bangchang K.

Malar J. 2011 Feb 16;10:44. doi: 10.1186/1475-2875-10-44.

8.

Malaria distribution, prevalence, drug resistance and control in Indonesia.

Elyazar IR, Hay SI, Baird JK.

Adv Parasitol. 2011;74:41-175. doi: 10.1016/B978-0-12-385897-9.00002-1. Review.

9.

Artemisinin combination therapy for vivax malaria.

Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN.

Lancet Infect Dis. 2010 Jun;10(6):405-16. doi: 10.1016/S1473-3099(10)70079-7. Review.

10.

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.

Awab GR, Pukrittayakamee S, Imwong M, Dondorp AM, Woodrow CJ, Lee SJ, Day NP, Singhasivanon P, White NJ, Kaker F.

Malar J. 2010 Apr 21;9:105. doi: 10.1186/1475-2875-9-105.

11.

Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.

Kinzer MH, Chand K, Basri H, Lederman ER, Susanti AI, Elyazar I, Taleo G, Rogers WO, Bangs MJ, Maguire JD.

Malar J. 2010 Apr 6;9:89. doi: 10.1186/1475-2875-9-89.

12.

Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia.

Sutanto I, Endawati D, Ling LH, Laihad F, Setiabudy R, Baird JK.

Malar J. 2010 Feb 12;9:52. doi: 10.1186/1475-2875-9-52.

13.

Resistance to therapies for infection by Plasmodium vivax.

Baird JK.

Clin Microbiol Rev. 2009 Jul;22(3):508-34. doi: 10.1128/CMR.00008-09. Review.

14.

Acquired immunity to malaria.

Doolan DL, DobaƱo C, Baird JK.

Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents. doi: 10.1128/CMR.00025-08. Review.

15.

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.

Hasugian AR, Tjitra E, Ratcliff A, Siswantoro H, Kenangalem E, Wuwung RM, Purba HL, Piera KA, Chalfien F, Marfurt J, Penttinen PM, Russell B, Anstey NM, Price RN.

Antimicrob Agents Chemother. 2009 Mar;53(3):1094-9. doi: 10.1128/AAC.01511-08. Epub 2008 Dec 22.

16.

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.

Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S.

Am J Trop Med Hyg. 2008 May;78(5):736-40.

17.

Chloroquine-resistant Plasmodium vivax, Brazilian Amazon.

de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa Md, Alecrim WD, Alecrim Md.

Emerg Infect Dis. 2007 Jul;13(7):1125-6. doi: 10.3201/eid1307.061386. No abstract available.

18.

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.

Lederman ER, Maguire JD, Sumawinata IW, Chand K, Elyazar I, Estiana L, Sismadi P, Bangs MJ, Baird JK.

Malar J. 2006 Nov 14;5:108.

19.

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.

Ratcliff A, Siswantoro H, Kenangalem E, Wuwung M, Brockman A, Edstein MD, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN.

Trans R Soc Trop Med Hyg. 2007 Apr;101(4):351-9. Epub 2006 Oct 9.

20.

Chloroquine resistance in Plasmodium vivax.

Baird JK.

Antimicrob Agents Chemother. 2004 Nov;48(11):4075-83. Review. No abstract available.

Supplemental Content

Support Center